Drug Substance Development: Comprehensive Network and Capabilities
fact sheet
internal
Comprised of more than 150 scientists in four countries, we exceed expectations on even the most challenging projects.
Working in state-of-the-art laboratories equipped with the latest process and analytical instrumentation, we efficiently
conduct route scouting, rapid process development and optimization of reaction conditions for scale-up of materials for
preclinical trials or large-scale manufacturing, including non-GMP and GMP.